Related Experiment Video
Updated: Jul 6, 2026
07:08
Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
Published on: March 6, 2018
Avoiding paraphenylenediamine exposure in children
Tamar Zapolanski1, Sharon E Jacob
1Department of Dermatology, University of Miami, Miami, Florida, USA.
Pediatric Annals
|March 14, 2008
Summary
Para-phenylenediamine (PPD) is a common allergen, especially in temporary tattoos and hair dyes, posing risks to children and increasing sensitization. Awareness and avoidance are crucial to prevent unnecessary PPD exposure in pediatric populations.
Area of Science:
- Dermatology
- Allergology
- Toxicology
Background:
- Para-phenylenediamine (PPD) is a well-documented allergen.
- The American Contact Dermatitis Society designated PPD as the 2006 "allergen of the year" to highlight emerging exposure patterns and rising sensitization rates.
- Temporary tattoos and adolescent hair dyeing represent significant, yet often overlooked, sources of PPD exposure.
Purpose of the Study:
- To raise awareness regarding the risks associated with para-phenylenediamine (PPD) exposure.
- To highlight the role of temporary tattoos and hair dyes as common vehicles for PPD sensitization, particularly in children.
- To advocate for increased vigilance and reduced unnecessary PPD usage in pediatric populations.
Main Methods:
- Review of existing literature on PPD allergies and sensitization.
- Analysis of exposure patterns, focusing on temporary tattoos and hair dyes.
- Identification of at-risk demographics, including children and adolescents.
Main Results:
- Temporary tattoos are a significant source of PPD exposure, especially relevant for children.
- PPD sensitization from these sources is a global concern, affecting American tourists internationally.
- Adolescents using hair dyes are also identified as a high-risk group for PPD sensitization.
Conclusions:
- Increased awareness of PPD's allergenic potential and exposure routes is necessary.
- Preventive measures should focus on reducing the unnecessary use of PPD, particularly in children.
- Public health initiatives are needed to mitigate risks associated with PPD in consumer products like temporary tattoos and hair dyes.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:26Physical Properties of Amines
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...